المؤلفون: Lu, Min, Zhu, Li-Xia, Yan, Ji-Ling, Wang, Ying-Zheng, Zhao, Xia, Zhou, Ying, Cui, Yi-Min

المساهمون: Cui, YM (reprint author), Peking Univ, Hosp 1, Base Clin Trial, Dept Pharm, 6 Da Hong Luo Chang St, Beijing 100034, Peoples R China., Peking Univ, Hosp 1, Base Clin Trial, Dept Pharm, 6 Da Hong Luo Chang St, Beijing 100034, Peoples R China., CSPC Zhongqi Pharmaceut Technol Shijiazhuang Co L, Dept Clin Med, Shijiazhuang, Hebei, Peoples R China.

المصدر: SCI

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonist, pharmacokinetics, pharmacodynamics, tolerability, healthy Chinese subjects, SYNTHETIC EXENDIN-4, GLYCEMIC CONTROL, ZUCKER RATS, EXENATIDE, GLUCOSE, BIOLOGY, VENOM

العلاقة: INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE.2017,10(5),8018-8024.; 1910613; http://hdl.handle.net/20.500.11897/476005Test; WOS:000402294200073

الإتاحة: https://doi.org/20.500.11897/476005Test
https://hdl.handle.net/20.500.11897/476005Test

المؤلفون: Zang, Yan-Nan, Zhang, Min-Jie, Wang, Yi-Tong, Wang, Chen, Wang, Qian, Zheng, Qing-Shan, Ji, Li-Nong, Guo, Wei, Fang, Yi

المساهمون: Guo, W (reprint author), Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Dept Pharm, 5 Ankang Lane,Dewai Ave, Beijing 100088, Peoples R China., Fang, Y (reprint author), Peking Univ Peoples Hosp, Dept Pharm, 11,Xizhimen South St, Beijing 100044, Peoples R China., Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Dept Pharm, 5 Ankang Lane,Dewai Ave, Beijing 100088, Peoples R China., Peking Univ Peoples Hosp, Dept Pharm, 11,Xizhimen South St, Beijing 100044, Peoples R China., Shanghai Univ Chinese Med, Ctr Drug Clin Res, Shanghai, Peoples R China., Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China.

المصدر: SCI

مصطلحات موضوعية: lyophilized recombinant glucagon-like peptide-1 receptor agonist (recombinant exendin-4, rE-4), population pharmacokinetics, two-compartment model, LIRAGLUTIDE PHARMACOKINETICS, EXENATIDE, MODEL, RATS

العلاقة: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS.2017,55(8),650-658.; 1905875; http://hdl.handle.net/20.500.11897/471775Test; WOS:000406517100003

الإتاحة: https://doi.org/20.500.11897/471775Test
https://doi.org/10.5414/CP202973Test
https://hdl.handle.net/20.500.11897/471775Test

المؤلفون: Liu, Limei, Liu, Jian, Gao, Yuansheng, Ng, Chi Fai, Yu, Xiaoxing, Dou, Dou, Huang, Yu

المساهمون: Liu, LM (reprint author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China., Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China., Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China., Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China., Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.

المصدر: PubMed ; SCI

مصطلحات موضوعية: glucagon-like peptide-1 receptor, hypertension, protein kinase C, renal artery, GLP-1 RECEPTOR, BLOOD-PRESSURE, INDEPENDENT PATHWAYS, PKC-BETA, ACTIVATION, PHOSPHORYLATION, SITAGLIPTIN, SENSITIVITY, INHIBITION, EXENDIN-4

العلاقة: JOURNAL OF HYPERTENSION.2015,33,(4),784-790.; 649455; http://hdl.handle.net/20.500.11897/341282Test; WOS:000351956700017

الإتاحة: https://doi.org/20.500.11897/341282Test
https://doi.org/10.1097/HJH.0000000000000480Test
https://hdl.handle.net/20.500.11897/341282Test

المؤلفون: Wang, T., Wang, F., Gou, Z., Tang, H., Li, C., Shi, L., Zhai, S.

المساهمون: Zhai, S (reprint author), Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China., Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100871, Peoples R China., Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT USA., Harbin Med Univ, Affiliated Hosp 1, Dept Pharm, Harbin, Peoples R China., Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China.

المصدر: PubMed ; SCI

مصطلحات موضوعية: acute pancreatitis, case-control study, cohort study, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, incretin-based therapies, meta-analysis, observational study, AMERICAN-DIABETES-ASSOCIATION, RANDOMIZED CLINICAL-TRIALS, EUROPEAN-ASSOCIATION, CONSENSUS STATEMENT, ADVERSE EVENTS, EXENATIDE, POPULATION, CANCER, DRUGS

العلاقة: DIABETES OBESITY & METABOLISM.2015,17,(1),32-41.; 652820; http://hdl.handle.net/20.500.11897/156322Test; WOS:000348848300006

الإتاحة: https://doi.org/20.500.11897/156322Test
https://doi.org/10.1111/dom.12386Test
https://hdl.handle.net/20.500.11897/156322Test

المؤلفون: Sun, Feng, Yu, Kai, Wu, Shanshan, Zhang, Yuan, Yang, Zhirong, Shi, Luwen, Ji, Linong, Zhan, Siyan

المساهمون: Zhan, SY (reprint author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, 38 Xueyuan Rd, Beijing 100191, Peoples R China., Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China., Peking Univ, Int Res Ctr Med Adm, Beijing 100191, Peoples R China., Shihezi Univ, Coll Med, Dept Prevent Med, Shihezi 832002, Peoples R China., Tianjin Fifth Cent Hosp, Dept Orthoped, Tianjin 300450, Peoples R China., Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100044, Peoples R China., Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, 38 Xueyuan Rd, Beijing 100191, Peoples R China.

المصدر: PubMed ; SCI

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Cardiovascular safety, Efficacy, Network meta-analysis, Type 2 diabetes mellitus, RANDOMIZED CLINICAL-TRIALS, MYOCARDIAL-INFARCTION, ANTIDIABETIC AGENTS, EXENATIDE TWICE, PARALLEL-GROUP, LIRAGLUTIDE, THERAPIES, INSULIN, DISEASE

العلاقة: DIABETES RESEARCH AND CLINICAL PRACTICE.2012,98,(3),386-395.; 659896; http://hdl.handle.net/20.500.11897/191955Test; WOS:000312133700009

الإتاحة: https://doi.org/20.500.11897/191955Test
https://doi.org/10.1016/j.diabres.2012.09.004Test
https://hdl.handle.net/20.500.11897/191955Test